Voleon Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Voleon Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.86M	Sell	8,873 -737	-8%	-$564K	0.15%	150
2025 Q4	$7.42M	Sell	9,610 -16,108	-63%	-$10.9M	0.16%	136
2025 Q3	$14.5M	Buy	25,718 +7,055	+38%	+$3.99M	0.35%	55
2025 Q2	$9.8M	Buy	18,663 +17,419	+1,400%	+$9.72M	0.54%	34
2025 Q1	$789K	Buy	1,244 +573	+85%	+$394K	0.06%	228
2024 Q4	$478K	Buy	+671	New	+$563K	0.04%	255
2021 Q1	–	Sell	-41,500	Closed	-$20M	–	29
2020 Q4	$20M	Hold	41,500	–	–	2.14%	20
2020 Q3	$23.2M	Hold	41,500	–	–	8.84%	5
2020 Q2	$25.9M	Buy	+41,500	New	+$23.6M	10.85%	3

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Voleon Capital Management's REGN Position: Q1 2026 in Review

Voleon Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 7.7% in Q1 2026, selling an estimated $564K and leaving 8,873 shares worth $6.86M. The position accounts for 0.15% of the portfolio, ranked #150.

Voleon Capital Management first reported a position in REGN in Q2 2020 and has held it in 9 quarters since. The position peaked at $25.9M in Q2 2020. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Voleon Capital Management held 8,873 shares of Regeneron Pharmaceuticals worth $6.86M as of Q1 2026.
Voleon Capital Management sold 737 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $564K.
Regeneron Pharmaceuticals made up 0.15% of Voleon Capital Management's portfolio in Q1 2026, its #150 holding.
Voleon Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
Voleon Capital Management's Regeneron Pharmaceuticals position peaked at $25.9M in Q2 2020.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.